# Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning

**Authors:** Alec D. McCarthy, Kay Durairaj, Jacob Linneman‐Heath, Dusan Sajic, Mara Dacso, Alan Durkin

PMC · DOI: 10.1111/jocd.70670 · Journal of Cosmetic Dermatology · 2026-01-12

## TL;DR

Public interest in weight loss drugs like Ozempic is rising, along with growing awareness of facial side effects such as volume loss and skin laxity.

## Contribution

This study quantifies the correlation between public interest in GLP-1 RAs and awareness of their facial aesthetic effects using Google Trends data.

## Key findings

- RSV for 'Ozempic' increased steadily from November 2021 to December 2024.
- Searches for 'Ozempic face' rose by 4600%, indicating growing public concern about facial aesthetic effects.
- Queries related to plastic surgeons addressing Ozempic face also increased significantly.

## Abstract

Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have gained rapid popularity for both medical and consumer‐directed weight loss. This growth has been accompanied by increased public discussion regarding facial aesthetic changes, commonly referred to as “Ozempic face,” characterized by volume depletion and cutaneous laxity.

To quantify temporal patterns of public search interest in a widely known GLP‐1 RA and evaluate corresponding awareness of its cosmetic facial sequelae using infodemiologic methods.

Google Trends data for “Ozempic” and related frequently co‐searched queries were analyzed from November 2021 to December 2024. Trends in relative search volume (RSV) were examined, with particular focus on terms associated with facial aesthetics, including “Ozempic face” and “plastic surgeons Ozempic face.”

RSV for “Ozempic” showed a steady upward trajectory over the study period. Queries related to facial aesthetic consequences exhibited substantial proportional increases. Notably, “Ozempic face” demonstrated a 4600% rise in RSV, and searches for “plastic surgeons Ozempic face” similarly grew markedly.

Public interest in GLP‐1 RAs is strongly associated with rising awareness and concern about their facial aesthetic effects. These trends suggest that aesthetic practitioners should expect more patient inquiries regarding GLP‐1–related facial changes and should proactively integrate counseling and corrective treatment options into clinical practice.

## Full-text entities

- **Genes:** GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}
- **Diseases:** Weight Loss (MESH:D015431), cutaneous laxity (MESH:D007593)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12793942/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12793942/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12793942/full.md

---
Source: https://tomesphere.com/paper/PMC12793942